Mayarling Francisca Troncoso1, Mario Pavez1, Carlos Wilson1, Daniel Lagos1, Javier Duran1, Sebastián Ramos1, Genaro Barrientos1, Patricio Silva2, Paola Llanos3, Carla Basualto-Alarcón4,5, B Daan Westenbrink6, Sergio Lavandero7,8, Manuel Estrada9. 1. Programa de Fisiología Y Biofísica, Facultad de Medicina, Instituto de Ciencias Biomédicas (ICBM), Universidad de Chile, 8389100, Independencia, Santiago, Chile. 2. Faculty of Health Science, Universidad Central de Chile, Santiago, Chile. 3. Institute for Research in Dental Sciences, Faculty of Dentistry, Universidad de Chile, Santiago, Chile. 4. Departamento de Ciencias de la Salud, Universidad de Aysén, 5951537, Coyhaique, Chile. 5. Departamento de Anatomía y Medicina Legal, Facultad de Medicina, Universidad de Chile, 8389100, Santiago, Chile. 6. Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands. 7. Advanced Center for Chronic Diseases (ACCDiS), Facultad Ciencias Químicas y Farmacéuticas and Facultad de Medicina, Universidad de Chile, Santiago, Chile. 8. Department of Internal Medicine (Cardiology Division), University of Texas Southwestern Medical Center, Dallas, TX, USA. 9. Programa de Fisiología Y Biofísica, Facultad de Medicina, Instituto de Ciencias Biomédicas (ICBM), Universidad de Chile, 8389100, Independencia, Santiago, Chile. iestrada@med.uchile.cl.
Abstract
BACKGROUND: Testosterone regulates nutrient and energy balance to maintain protein synthesis and metabolism in cardiomyocytes, but supraphysiological concentrations induce cardiac hypertrophy. Previously, we determined that testosterone increased glucose uptake-via AMP-activated protein kinase (AMPK)-after acute treatment in cardiomyocytes. However, whether elevated glucose uptake is involved in long-term changes of glucose metabolism or is required during cardiomyocyte growth remained unknown. In this study, we hypothesized that glucose uptake and glycolysis increase in testosterone-treated cardiomyocytes through AMPK and androgen receptor (AR). METHODS: Cultured cardiomyocytes were stimulated with 100 nM testosterone for 24 h, and hypertrophy was verified by increased cell size and mRNA levels of β-myosin heavy chain (β-mhc). Glucose uptake was assessed by 2-NBDG. Glycolysis and glycolytic capacity were determined by measuring extracellular acidification rate (ECAR). RESULTS: Testosterone induced cardiomyocyte hypertrophy that was accompanied by increased glucose uptake, glycolysis enhancement and upregulated mRNA expression of hexokinase 2. In addition, testosterone increased AMPK phosphorylation (Thr172), while inhibition of both AMPK and AR blocked glycolysis and cardiomyocyte hypertrophy induced by testosterone. Moreover, testosterone supplementation in adult male rats by 5 weeks induced cardiac hypertrophy and upregulated β-mhc, Hk2 and Pfk2 mRNA levels. CONCLUSION: These results indicate that testosterone stimulates glucose metabolism by activation of AMPK and AR signaling which are critical to induce cardiomyocyte hypertrophy.
BACKGROUND:Testosterone regulates nutrient and energy balance to maintain protein synthesis and metabolism in cardiomyocytes, but supraphysiological concentrations induce cardiac hypertrophy. Previously, we determined that testosterone increased glucose uptake-via AMP-activated protein kinase (AMPK)-after acute treatment in cardiomyocytes. However, whether elevated glucose uptake is involved in long-term changes of glucose metabolism or is required during cardiomyocyte growth remained unknown. In this study, we hypothesized that glucose uptake and glycolysis increase in testosterone-treated cardiomyocytes through AMPK and androgen receptor (AR). METHODS: Cultured cardiomyocytes were stimulated with 100 nM testosterone for 24 h, and hypertrophy was verified by increased cell size and mRNA levels of β-myosin heavy chain (β-mhc). Glucose uptake was assessed by 2-NBDG. Glycolysis and glycolytic capacity were determined by measuring extracellular acidification rate (ECAR). RESULTS:Testosterone induced cardiomyocyte hypertrophy that was accompanied by increased glucose uptake, glycolysis enhancement and upregulated mRNA expression of hexokinase 2. In addition, testosterone increased AMPK phosphorylation (Thr172), while inhibition of both AMPK and AR blocked glycolysis and cardiomyocyte hypertrophy induced by testosterone. Moreover, testosterone supplementation in adult male rats by 5 weeks induced cardiac hypertrophy and upregulated β-mhc, Hk2 and Pfk2 mRNA levels. CONCLUSION: These results indicate that testosterone stimulates glucose metabolism by activation of AMPK and AR signaling which are critical to induce cardiomyocyte hypertrophy.
Authors: J M Vicencio; M Estrada; D Galvis; R Bravo; A E Contreras; D Rotter; G Szabadkai; J A Hill; B A Rothermel; E Jaimovich; S Lavandero Journal: Mini Rev Med Chem Date: 2011-05 Impact factor: 3.862
Authors: Robert W Myers; Hong-Ping Guan; Juliann Ehrhart; Aleksandr Petrov; Srinivasa Prahalada; Effie Tozzo; Xiaodong Yang; Marc M Kurtz; Maria Trujillo; Dinko Gonzalez Trotter; Danqing Feng; Shiyao Xu; George Eiermann; Marie A Holahan; Daniel Rubins; Stacey Conarello; Xiaoda Niu; Sandra C Souza; Corin Miller; Jinqi Liu; Ku Lu; Wen Feng; Ying Li; Ronald E Painter; James A Milligan; Huaibing He; Franklin Liu; Aimie Ogawa; Douglas Wisniewski; Rory J Rohm; Liyang Wang; Michelle Bunzel; Ying Qian; Wei Zhu; Hongwu Wang; Bindu Bennet; Lisa LaFranco Scheuch; Guillermo E Fernandez; Cai Li; Michael Klimas; Gaochao Zhou; Margaret van Heek; Tesfaye Biftu; Ann Weber; David E Kelley; Nancy Thornberry; Mark D Erion; Daniel M Kemp; Iyassu K Sebhat Journal: Science Date: 2017-07-13 Impact factor: 47.728
Authors: A S Marsin; L Bertrand; M H Rider; J Deprez; C Beauloye; M F Vincent; G Van den Berghe; D Carling; L Hue Journal: Curr Biol Date: 2000-10-19 Impact factor: 10.834
Authors: Javier Duran; Daniel Lagos; Mario Pavez; Mayarling F Troncoso; Sebastián Ramos; Genaro Barrientos; Cristian Ibarra; Sergio Lavandero; Manuel Estrada Journal: Front Pharmacol Date: 2017-09-11 Impact factor: 5.810
Authors: Simon A Hawley; Jérôme Boudeau; Jennifer L Reid; Kirsty J Mustard; Lina Udd; Tomi P Mäkelä; Dario R Alessi; D Grahame Hardie Journal: J Biol Date: 2003-09-24
Authors: J B Tennakoon; Y Shi; J J Han; E Tsouko; M A White; A R Burns; A Zhang; X Xia; O R Ilkayeva; L Xin; M M Ittmann; F G Rick; A V Schally; D E Frigo Journal: Oncogene Date: 2013-11-04 Impact factor: 9.867
Authors: N R Strogulski; A Kopczynski; V G de Oliveira; R B Carteri; G Hansel; G T Venturin; S Greggio; J C DaCosta; M A De Bastiani; M S Rodolphi; L V Portela Journal: Neurochem Res Date: 2022-04-12 Impact factor: 3.996